180 related articles for article (PubMed ID: 19509478)
1. Inhibitory effects of retinoic acid on invasiveness of human thyroid carcinoma cell lines in vitro.
Lan L; Cui D; Luo Y; Shi BY; Deng LL; Zhang GY; Wang H
J Endocrinol Invest; 2009 Oct; 32(9):731-8. PubMed ID: 19509478
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of retinoic acid on extracellular matrix degradation and attachment behaviour in follicular thyroid carcinoma cell lines.
Havekes B; Schröder van der Elst JP; van der Pluijm G; Goslings BM; Romijn JA; Smit JW
J Endocrinol; 2000 Nov; 167(2):229-38. PubMed ID: 11054636
[TBL] [Abstract][Full Text] [Related]
3. [Beneficial effects of retinoic acid on in vitro invasiveness of human thyroid carcinoma cell lines].
Lan L; Cui D; Luo Y; Shi BY; Deng LL; Zhang GY; Deng W; Wang H
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(34):2407-11. PubMed ID: 21092511
[TBL] [Abstract][Full Text] [Related]
4. Non-thermal atmospheric pressure plasma inhibits thyroid papillary cancer cell invasion via cytoskeletal modulation, altered MMP-2/-9/uPA activity.
Chang JW; Kang SU; Shin YS; Kim KI; Seo SJ; Yang SS; Lee JS; Moon E; Lee K; Kim CH
PLoS One; 2014; 9(3):e92198. PubMed ID: 24667444
[TBL] [Abstract][Full Text] [Related]
5. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system.
Smit JW; van der Pluijm G; Romijn HA; Löwik CW; Morreau H; Goslings BM
Thyroid; 1999 Sep; 9(9):913-9. PubMed ID: 10524570
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
Hoffmann S; Rockenstein A; Ramaswamy A; Celik I; Wunderlich A; Lingelbach S; Hofbauer LC; Zielke A
Mol Cell Endocrinol; 2007 Jan; 264(1-2):74-81. PubMed ID: 17101211
[TBL] [Abstract][Full Text] [Related]
7. Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses.
Schmutzler C; Hoang-Vu C; Rüger B; Köhrle J
Eur J Endocrinol; 2004 Apr; 150(4):547-56. PubMed ID: 15080786
[TBL] [Abstract][Full Text] [Related]
8. Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues.
schmutzler C; Brtko J; Winzer R; Jakobs TC; Meissner-Weigl J; Simon D; Goretzki PE; Köhrle J
Int J Cancer; 1998 May; 76(3):368-76. PubMed ID: 9579574
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells.
Nowicki TS; Kummer NT; Iacob C; Suslina N; Schaefer S; Schantz S; Shin E; Moscatello AL; Tiwari RK; Geliebter J
Laryngoscope; 2010 Jul; 120(7):1383-90. PubMed ID: 20578104
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines.
Baldini E; Presutti D; Favoriti P; Santini S; Papoff G; Tuccilli C; Carletti R; Di Gioia C; Lori E; Ferent IC; Gagliardi F; Catania A; Pironi D; Tripodi D; D'Andrea V; Sorrenti S; Ruberti G; Ulisse S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409084
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells.
Catalano MG; Fortunati N; Pugliese M; Marano F; Ortoleva L; Poli R; Asioli S; Bandino A; Palestini N; Grange C; Bussolati B; Boccuzzi G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1150-9. PubMed ID: 22563106
[TBL] [Abstract][Full Text] [Related]
12. Human thyroid carcinoma cell invasion is controlled by the low density lipoprotein receptor-related protein-mediated clearance of urokinase plasminogen activator.
Sid B; Dedieu S; Delorme N; Sartelet H; Rath GM; Bellon G; Martiny L
Int J Biochem Cell Biol; 2006; 38(10):1729-40. PubMed ID: 16807059
[TBL] [Abstract][Full Text] [Related]
13. [All-trans retinoic acid improves iodine uptake of thyroid cancer cells via repressing transcriptional activity of β-catenin].
Lan L; Deng W; Chen HL; Huo LL; Deng LL; Zhang GY; Luo Y
Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(7):553-8. PubMed ID: 26902198
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines.
Trojanowicz B; Winkler A; Hammje K; Chen Z; Sekulla C; Glanz D; Schmutzler C; Mentrup B; Hombach-Klonisch S; Klonisch T; Finke R; Köhrle J; Dralle H; Hoang-Vu C
J Mol Endocrinol; 2009 Mar; 42(3):249-60. PubMed ID: 19060179
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1 enhances human thyroid carcinoma cell invasion through urokinase activity.
Sid B; Langlois B; Sartelet H; Bellon G; Dedieu S; Martiny L
Int J Biochem Cell Biol; 2008; 40(9):1890-900. PubMed ID: 18321763
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
17. S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
Devine KM; Smicun Y; Hope JM; Fishman DA
Gynecol Oncol; 2008 Aug; 110(2):237-45. PubMed ID: 18513786
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through Focal adhesion kinase.
Rothhut B; Ghoneim C; Antonicelli F; Soula-Rothhut M
Biochimie; 2007 May; 89(5):613-24. PubMed ID: 17397984
[TBL] [Abstract][Full Text] [Related]
19. Differential pattern of integrin receptor expression in differentiated and anaplastic thyroid cancer cell lines.
Hoffmann S; Maschuw K; Hassan I; Reckzeh B; Wunderlich A; Lingelbach S; Zielke A
Thyroid; 2005 Sep; 15(9):1011-20. PubMed ID: 16187909
[TBL] [Abstract][Full Text] [Related]
20. The role of CD147 in the invasiveness of follicular thyroid carcinoma cells.
Omi Y; Shibata N; Okamoto T; Obara T; Kobayashi M
Thyroid; 2012 Apr; 22(4):383-94. PubMed ID: 22280229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
